Oncology Care Management Programs

Oncology care management programs are structured, multidisciplinary frameworks that coordinate clinical, supportive, and navigational services for individuals diagnosed with cancer. These programs operate across the full cancer continuum — from diagnosis through active treatment, survivorship, and, where applicable, end-of-life care. Understanding their structure, regulatory grounding, and operational scope is essential for health professionals, payers, and health system administrators engaged in complex care management and value-based care arrangements.

Definition and scope

Oncology care management is a subspecialty within the broader field of care management that addresses the clinical complexity, high cost, and psychosocial burden associated with cancer diagnoses. The Centers for Medicare & Medicaid Services (CMS) formally recognized oncology-specific care management structures through the Oncology Care Model (OCM), a multi-payer payment and care delivery model tested between 2016 and 2022 under the CMS Innovation Center (CMMI). The OCM required participating practices to provide 24/7 patient access to clinicians, care navigation, care planning aligned with the Institute of Medicine's 13 components of high-quality cancer care, and evidence-based treatment according to nationally recognized guidelines such as those from the National Comprehensive Cancer Network (NCCN).

The scope of oncology care management extends across three broadly defined patient populations:

Active treatment patients — individuals receiving chemotherapy, radiation, immunotherapy, targeted therapy, or surgical oncology services
Survivorship patients — individuals who have completed primary treatment and require long-term monitoring, late-effect management, and health behavior support
Palliative and end-of-life patients — individuals whose goals of care shift toward comfort, symptom management, and family support (see also palliative care management)

Oncology care management differs structurally from general chronic disease care management in that it must integrate oncology-specific clinical pathways, treatment toxicity monitoring, and episodic cost tracking alongside longitudinal coordination functions.

How it works

Oncology care management programs typically follow a phased coordination model built on risk stratification in care management principles. CMS and NCCN-aligned programs generally operationalize care management through the following discrete phases:

Enrollment and intake — Identification of eligible patients through diagnosis codes (ICD-10-CM malignancy codes), payer claims data, or practice referral. Eligibility typically includes patients initiating a six-month chemotherapy episode.
Comprehensive assessment — Evaluation of clinical status, functional capacity, social determinants of health, psychological distress (measured with validated tools such as the NCCN Distress Thermometer), caregiver burden, and health literacy.
Care plan development — Creation of a patient-centered plan that incorporates treatment intent, advanced care planning, and survivorship goals. This aligns with CMS Conditions of Participation requirements under 42 CFR Part 482 and with patient-centered care planning standards.
Active coordination and navigation — Ongoing communication among oncology nurses, social workers, pharmacists, palliative care specialists, and primary care providers. Navigation functions address appointment adherence, symptom triage, and access to supportive services.
Transition and survivorship handoff — Structured discharge from active treatment coordination into survivorship care planning or, when appropriate, transitional care management protocols for post-hospitalization episodes.
Outcome monitoring — Tracking of quality metrics including unplanned hospitalizations, emergency department utilization, chemotherapy-related adverse events, and patient-reported outcomes.

The interdisciplinary composition of oncology care management teams typically includes oncology-certified nurses (OCNs, credentialed through the Oncology Nursing Certification Corporation, ONCC), licensed social workers, oncology pharmacists, and navigators. Team structure follows frameworks described in interdisciplinary care teams guidance.

Common scenarios

Oncology care management programs are activated across a range of clinical and administrative situations. The following scenarios represent the most operationally frequent applications:

High-cost chemotherapy episode management: Patients initiating systemic therapy generate the highest per-episode costs in oncology. CMS Episode Payment Model data from the OCM showed average chemotherapy episode costs exceeding $70,000 per 6-month episode across participating practices (CMS OCM Performance Period Results).
Acute symptom management and ED diversion: Programs intervene when patients experience chemotherapy toxicities — nausea, neutropenic fever, dehydration — that might otherwise drive unplanned emergency department visits. The OCM tracked "unplanned acute care" as a primary performance measure.
Psychosocial distress screening: NCCN Clinical Practice Guidelines in Oncology require distress screening at initial visit and at clinically indicated intervals. Care managers operationalize this screening and connect patients with behavioral health services (see behavioral health care management).
Advanced care planning facilitation: For patients with metastatic or recurrent disease, care managers facilitate advance directive completion, goals-of-care conversations, and palliative care referrals.
Survivorship care plan delivery: The American College of Surgeons Commission on Cancer (CoC) Standard 4.8 requires accredited cancer programs to provide survivorship care plans to patients completing curative-intent treatment.

Decision boundaries

Oncology care management operates within defined eligibility and escalation thresholds that distinguish it from adjacent care management models.

Oncology care management vs. general chronic disease care management: General chronic disease programs address conditions such as diabetes or heart failure with stable, longitudinal care needs. Oncology programs are episode-anchored, often time-limited to the active treatment phase, and require oncology-specific clinical competency. These distinctions are relevant to care-management-reimbursement-and-billing coding, where CMS differentiates Chronic Care Management (CCM, CPT 99490 series) from Principal Care Management (PCM, CPT 99424–99427), the latter of which is appropriate for single high-complexity conditions such as active cancer.

Escalation boundaries: Oncology care managers escalate to the treating oncologist when CTCAE (Common Terminology Criteria for Adverse Events, NCI) Grade 3 or higher toxicities are identified, when suicidality is present on psychosocial screening, or when a patient presents with acute oncologic emergencies (spinal cord compression, febrile neutropenia, hypercalcemia of malignancy).

Payer program boundaries: Medicare Advantage plans, commercial insurers, and Medicaid managed care organizations each set distinct enrollment criteria for oncology care management. CMS's Enhancing Oncology Model (EOM), which succeeded the OCM in 2023, restricts participation to practices treating patients with 1 of 7 cancer types: breast, chronic leukemia, small intestine/colorectal, lung, lymphoma, multiple myeloma, and prostate (CMS Enhancing Oncology Model). Practices outside EOM may still bill PCM codes or operate internal oncology navigation programs under institutional policy.

Care management accreditation: Programs seeking external validation may pursue accreditation through URAC (Oncology Pharmacy Services accreditation) or NCQA's Health Plan Accreditation standards, both of which include oncology care management quality domains. See care management accreditation bodies for classification of accrediting organizations.

References

Explore This Site

Regulations & Safety Regulatory References Tools & Calculators Bmi Health Metrics Calculator